Possible effects of fibroblast growth factor 21 on vascular calcification via suppressing activating transcription factor 4 mediated apoptosis and osteogenic transformation in rats

Cell Biochem Funct. 2022 Jun;40(4):349-358. doi: 10.1002/cbf.3698. Epub 2022 May 9.

Abstract

Vascular calcification (VC), a significant risk factor of many cardio-cerebral vascular diseases, is a perplexing issue with no effective treatment in clinical work up to now. Endoplasmic reticulum stress (ERS) mediated apoptosis has been proved to be a significant mechanism for initiating VC process. Activating transcription factor 4 (ATF4), a key transcription factor of ERS, is most closely associated with VC. Fibroblast growth factor 21 (FGF21), an atypical member of the FGFs family, has a protective biological function in various metabolic diseases by ERS pathways. However, the possible effects of FGF21 on VC by regulating ERS, especially through the ATF4 pathway, is still unclear. Our research provides the first evidence that exogenous FGF21 treatment can alleviate the vitamin D3 plus nicotine-induced VC at least in part via suppressing ATF4 mediated apoptosis and osteogenic transformation in rats.

Keywords: apoptosis; fibroblast growth factor 21; osteogenic transformation; transcription factor 4; vascular calcification.

MeSH terms

  • Activating Transcription Factor 4* / metabolism
  • Animals
  • Apoptosis
  • Endoplasmic Reticulum Stress
  • Fibroblast Growth Factors* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Vascular Calcification* / drug therapy
  • Vascular Calcification* / metabolism

Substances

  • Atf4 protein, rat
  • fibroblast growth factor 21
  • Activating Transcription Factor 4
  • Fibroblast Growth Factors